Skip to content
Medical Health Aged Care

PSA23: Canberran named Australian Pharmacist of the Year

Pharmaceutical Society of Australia (PSA) 2 mins read

28 July 2023

The Pharmaceutical Society of Australia (PSA) proudly announces Canberra pharmacist Elise Apolloni as the 2023 PSA Symbion Pharmacist of the Year.

Elise Apolloni MPS is the co-owner of Capital Chemist Wanniassa, in the Australian Capital Territory. Under her leadership, Capital Chemist Wanniassa has grown into an extended hours pharmacy offering more than 40 professional services tailored to the unique needs of her community.

Whether through social media or community open days, Elise and her team are constantly finding new ways to connect with the community. Realising the hardship that members of her community were experiencing, Elise launched the Capital Chemist Wanniassa Food Pantry and Book Library for local families in need. She has also lobbied local government to install a secure sharps disposal bin to facilitate safe sharps disposal and harm minimisation in her local community.

Elise invests in her education well above what is usually expected of a pharmacist, including as a Credentialled Diabetes Educator, a Licensed Mental Health First Aid Instructor and advocate, a volunteer crisis support counsellor, and an asthma educator. On top of these qualifications, Elise is also a Heart Foundation Health Professional Ambassador, and ambassador for local charity PANDSI, supporting women experiencing post-natal depression.

Presenting the award at PSA’s National Conference PSA23 in Sydney this morning, National President Dr Fei Sim congratulated Ms Apolloni on her achievements.

“PSA is proud to name Elise as Pharmacist of the Year 2023, recognising years of passion, dedication, and leadership in pharmacy practice,

“Elise and her team take such pride in caring for their local community. Every service is tailored to meet the needs of the community.

“I am aware that pharmacists who have worked closely with Elise have all spoken highly of Elise’s intelligence, tenacity and team spirit.” Dr Sim said.


Media contact:   Georgia Clarke   M: 0480 099 798      E:

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s 36,000 pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.

More from this category

  • Medical Health Aged Care, Political
  • 08/12/2023
  • 15:35
Health Services Union

Minns ministers must stop misleading on paramedic pay

The Minns government is misleading the public with deliberately inflated figures about what paramedics are paid, as it risks mass resignation and deregistration of one of its most skilled but underpaid workforces.In a note circulated to media, the Government has claimed its pay offer would lift a first year paramedic’s take home pay from $123,594 to $137,683.This is not a figure that has been put to the HSU and nor it accurate. The offer put to the Union proposes a paltry 11.4 per cent, four year increase to the base pay of first year paramedics, from $74,364 to $82,877.The so-called…

  • Medical Health Aged Care, Political
  • 08/12/2023
  • 14:11
Health Equity Matters

Darryl O’Donnell steps down as CEO of Health Equity Matters

Health Equity Matters pays tribute to chief executive officer, Adjunct Professor Darryl O’Donnell, who is stepping down after eight impactful years leading the organisation. Health Equity Matters president, Mark Orr AM, said O’Donnell had been a transformative leader. “Darryl became chief executive at a very challenging time for the organisation. In the years since, he has worked tirelessly to enhance its stability and sustainability. This has expanded our capacity and impact. “Among his many achievements, Darryl has most recently helped shape the work of the HIV Taskforce chaired by the Hon Mark Butler MP, and the LGBTIQA+ Health Ten Year…

  • Medical Health Aged Care
  • 08/12/2023
  • 12:07

EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic

SYDNEY, Australia and NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- EnGeneIC, an innovative biopharmaceutical company leading the field of armed antibody therapeutics for oncology, has achieved a significant milestone with the granting of FDA “Fast-Track” designation for its pancreatic cancer therapeutic. This approval underscores the potential of EnGeneIC’s unique approach to revolutionise pancreatic cancer treatment.Pancreatic ductal adenocarcinoma (PDAC) is a notoriously challenging and aggressive form of cancer, usually diagnosed in advanced stages, making curative treatment options limited.The FDA’s decision to grant “Fast-Track” status reflects the urgency and unmet medical need associated with PDAC. EnGeneIC’s EDVTM (EnGeneIC Dream Vector) has…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.